(Q35688213)

9 August 2017

1 reference

title

Potential new strategies to prevent the development of diabetic retinopathy (English)

1 reference

9 August 2017

Susanne Mohr

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Expert Opinion on Investigational Drugs

9 August 2017

published in

1 reference

9 August 2017

volume

13

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

189-198

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Protein kinase C activation and the development of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Suppression of diabetic retinopathy with angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Interleukin 1 signaling occurs exclusively via the type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Interleukin 1 in the brain: biology, pathology and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Therapeutic potential of anti-oxidants and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Cytokine regulation of endothelial cell function: from molecular level to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Caspases: killer proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Involvement of cellular proteolytic machinery in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Transducing signals of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Caspases: intracellular signaling by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

ICEBERG: a novel inhibitor of interleukin-1beta generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Direct transcriptional activation of human caspase-1 by tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta-converting enzyme-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.3.189

10.1517/13543784.13.3.189

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference